Steven Cohen Vincerx Pharma, Inc. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 674,193 shares of VINC stock, worth $175,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
674,193
Previous 674,193
-0.0%
Holding current value
$175,290
Previous $546,000
11.17%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VINC
# of Institutions
28Shares Held
11MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.7MShares$703,0400.03% of portfolio
-
Prosight Management, LP Dallas, TX2.21MShares$573,6910.43% of portfolio
-
Sage Rhino Capital LLC1.7MShares$442,8870.28% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$231,8460.02% of portfolio
-
Goldman Sachs Group Inc New York, NY631KShares$164,1700.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $5.51M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...